Prescription Prices Are A Problem For All Americans

On Monday, The Daily Wire posted an article about President Trump’s plan to lower prescription drug prices.

The article reports:

Americans have waited long enough, and now real relief from sky-high prescription drug prices is finally here. Recently, President Donald J. Trump signed a landmark Executive Order to end the decades-long injustice that has forced American families — especially Hispanic households — to pay more for lifesaving medications than almost anyone else in the world.

Hispanics, who are more likely to be uninsured or underinsured compared to other groups, are disproportionately burdened by high out-of-pocket prescription costs. In fact, according to the CDC, nearly one in four Hispanic adults report not taking prescribed medications due to cost, compared to just 13% of non-Hispanic White adults. This Executive Order directly addresses that disparity by demanding lower drug prices and making medications more affordable and accessible for millions of working families across the country.

The article notes:

For many Americans across the U.S., especially those economically impacted by high healthcare costs, this Executive Order is a game changer. Families working long hours, often balancing multiple jobs, should not have to choose between buying insulin for their children or groceries for the week. President Trump’s directive ensures that low-income patients, seniors, and working-class Americans will now have direct access to the same steep discounts that pharmaceutical companies give to patients overseas through government-negotiated prices.

That means bypassing the costly middlemen and securing medicines at “most-favored-nation” prices that reflect the best deal given to any other country in the world. If drug manufacturers refuse, the Order empowers the Secretary of Health and Human Services Robert F. Kennedy Jr. to act decisively: impose these pricing standards through regulation and take additional aggressive steps to drive costs down. This is what America First leadership looks like.

The article concludes:

In an era where politicians too often offer empty promises and soaring rhetoric, President Trump delivers. His commitment to reforming healthcare pricing is not just about economics—it’s about justice. And make no mistake: justice is exactly what millions of Americans, especially those in underserved communities, have been demanding for years.

President Trump said it best: “Our citizens pay massively higher prices than other nations pay for the same exact pill, from the same factory.” That ends now.

This is more than an Executive Order. It’s a promise fulfilled, a burden lifted, and another bold move in President Trump’s mission to restore prosperity, fairness, and dignity to the American people.

Even with medical insurance and medicare supplement policies, some commonly prescribed drugs are very expensive.

Another Good Program Bites The Dust

Legal Insurrection is reporting today that the Biden administration is taking steps to remove the Trump administration policy put in place to lower the cost of insulin and epi-pens.

The article reports:

Biden’s bid to retract the rule was approved on Monday, as reported by Politico, with the expectation that the Department of Health and Human Services could publish the retraction within the coming days.

The measure, signed off on under the previous administration in December, aimed to require some 340B community health centers to deliver savings to low-income patients for insulin and epinephrine in a bid to bring down unaffordable prices.

Spokespeople for the White House and the Department of Health and Human Services did not return FOX Business’ request for comment.

The article notes:

Just after Biden was Inaugurated, USA Today “fact checked” the claim that such a move was planned. Once again, the press is forced to do a fact-reversal, one in a long stream of many we have covered at Legal Insurrection.

For diabetic patients, out-of-pocket costs for insulin can be a major expense, whether they are insured in the commercial market, enrolled in Medicare, or have no insurance. The savings Trump created was substantial.

The current group of fact-checkers have a rather questionable track record. It should be noted that most of the things ‘fact-checked’ are things that might portray President Trump in a good light or President Biden in a bad light.

The article concludes:

The Biden administration said Friday it has no timeline on whether it will allow states to import drugs from Canada, an effort that was approved under President Donald Trump as a key strategy to control costs.

Six states have passed laws to start such programs, and Florida, Colorado and New Mexico are the furthest along in plans to get federal approval.

The Biden administration said states still have several hurdles to get through, including a review by the Food and Drug Administration, and such efforts may face pressures from the Canadian government, which has warned its drug industry not to do anything that could cause drug shortages in that country.

“Although two proposals have been submitted to FDA, no timeline exists for the agency to make a decision. Thus, the possible future injuries to Plaintiffs’ members are overly speculative and not imminent,” the Biden administration wrote in a court filing late Friday seeking to dismiss a lawsuit from the Pharmaceutical Research and Manufacturers of America, an industry trade group. Drugmakers are asking the court to overturn the rule set by the Health and Human Services Department in October that for the first time approved allowing states to import drugs from Canada.

The Biden presidency is proving to be very costly and painful for average Americans.

The information in this article is also found at Fox News and Politico.